FLAG-IDA FOR RELAPSED/REFRACTORY ACUTE MYELOID LEUKAEMIA: A SINGLE CENTRE 5-YEAR STUDY

被引：0
|
作者：
Agbuduwe, C. [1 ]
Follows, G. [1 ]
Craig, J. [1 ]
Uttenthal, B. [1 ]
Crawley, C. [1 ]
Krishnamurthy, P. [1 ]
机构：
[1] Cambridge Univ Hosp NHS Trust, Haematol, Cambridge, England
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E938
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [21] Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases
    Paydas, S
    Yavuz, S
    Disel, U
    ANNALS OF HEMATOLOGY, 2006, 85 (01) : 63 - 63
  • [22] Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases
    Semra Paydas
    Sinan Yavuz
    Umut Disel
    Annals of Hematology, 2006, 85 : 63 - 63
  • [23] Differential Outcomes of Salvage with FLAG-IDA and Venetoclax-Based Regimens in Relapsed and Refractory Acute Myeloid Leukemia
    Bouligny, Ian M.
    Maher, Keri R.
    BLOOD, 2021, 138
  • [24] FLAG-IDA REGIMEN IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOBLASTIC LEUKEMIA: SINGLE-CENTER EXPERIENCE
    Genadieva-Stavrik, G.
    Georgievski, B.
    Cevreska, L.
    Karanfilski, O.
    Pivkova, A.
    Stojanoski, Z.
    Krstevska-Balkanov, S.
    Dukovski, D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 560 - 561
  • [25] FLAG-Ida regimen for therapy of relapsed acute leukaemia after allogeneic blood stem cell transplantation (a single-centre experience)
    Zavrelova, A.
    Zak, P.
    Cermanova, M.
    Jebavy, L.
    Doskocilova, K.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S311 - S311
  • [26] Outcomes of FLAG-IDA Versus MEC in Relapsed or Refractory AML
    Bouligny, Ian M.
    Murray, Graeme
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Maher, Keri
    BLOOD, 2022, 140 : 11742 - 11743
  • [27] A prognostic model for survival after salvage treatment with FLAG-Ida plus /- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia
    Bergua, Juan M.
    Montesinos, Pau
    Martinez-Cuadron, David
    Fernandez-Abellan, Pascual
    Serrano, Josefina
    Sayas, Maria J.
    Prieto-Fernandez, Julio
    Garcia, Raimundo
    Garcia-Huerta, Ana J.
    Barrios, Manuel
    Benavente, Celina
    Perez-Encinas, Manuel
    Simiele, Adriana
    Rodriguez-Macias, Gabriela
    Herrera-Puente, Pilar
    Rodriguez-Veiga, Rebeca
    Martinez-Sanchez, Maria P.
    Amador-Barciela, Maria L.
    Riaza-Grau, Rosalia
    Sanz, Miguel A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (05) : 700 - 710
  • [28] FOLLOW-UP UPDATE OF THE FLAG-IDA REGIMEN AS BRIDGE THERAPY TO ALLOTRANSPLANTATION IN REFRACTORY/ RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS: 10 YEAR-RESULTS FROM A SINGLE CENTRE EXPERIENCE
    Delia, Mario
    Gagliardi, Vito Pier
    Carluccio, Paola
    Contento, Corinne
    Di Gennaro, Daniela
    Strafella, Wanda
    Attolico, Immacolata
    Albano, Francesco
    Musto, Pellegrino
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 174 - 175
  • [29] FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies
    Mustafa, Omima
    Abdalla, Khalid
    AlAzmi, Aeshah A.
    Elimam, Naglla
    Abrar, Mohammed Burhan
    Jastaniah, Wasil
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1831 - 1838
  • [30] A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
    María P. Martínez Sánchez
    Juan Eduardo Megías-Vericat
    Rebeca Rodríguez-Veiga
    Susana Vives
    Juan Miguel Bergua
    Anna Torrent
    Sara Suárez-Varela
    Blanca Boluda
    Joaquín Martínez-López
    Isabel Cano-Ferri
    Evelyn Acuña-Cruz
    Laura Torres-Miñana
    Beatriz Martín-Herreros
    Alfons Serrano
    Amparo Sempere
    Eva Barragán
    Claudia Sargas
    Miguel Sanz
    David Martínez-Cuadrón
    Pau Montesinos
    Annals of Hematology, 2021, 100 : 1497 - 1508
12345